Novel Product for the Management of Coronary Ruptures Happening during Percutaneous Coronary Interventions

Abstract

Coronary artery perforation during percutaneous coronary interventions is a rare but dreaded complication. One of the treatment methods for this complication is the injection of an obliterating material into the ruptured vessel. We will introduce a novel material named “Spongostan” for embolization with significant advantages over available treatment options.